Excellent effects and possible mechanisms of action of a new antibody-drug conjugate against EGFR-positive triple-negative breast cancer.
Journal Information
Full Title: Mil Med Res
Abbreviation: Mil Med Res
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Military Medicine
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateThe research was approved by the Ethics Committee of the Institute of Medicinal Biotech, Chinese Academy of Medical Sciences (No. IMB-20200920D601). Consent for publicationAll the authors have reviewed the final version of manuscript and signed a written consent form for publication. Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."
"Funding This work was supported by the CAMS Innovation Fund for Medical Sciences (CIFMS) (2021-1-I2M-026), the Beijing Natural Science Foundation (7202133), and the Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences) (2021-RW350-002)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025